Literature DB >> 11734443

Cytokine balance in the lungs of patients with acute respiratory distress syndrome.

W Y Park1, R B Goodman, K P Steinberg, J T Ruzinski, F Radella, D R Park, J Pugin, S J Skerrett, L D Hudson, T R Martin.   

Abstract

Acute respiratory distress syndrome (ARDS) involves an intense inflammatory response in the lungs, with accumulation of both pro- and antiinflammatory cytokines in bronchoalveolar lavage fluid (BALF). Our goal was to determine how the balance between pro- and antiinflammatory mediators in the lungs changes before and after the onset of ARDS. We identified 23 patients at risk for ARDS and 46 with established ARDS and performed serial bronchoalveolar lavage (BAL). We used immunoassays to measure tumor necrosis factor alpha (TNF-alpha) and soluble TNF-alpha receptors I and II; interleukin 1 beta (IL-1 beta), IL-1 beta receptor antagonist, and soluble IL-1 receptor II; IL-6 and soluble IL-6 receptor; and IL-10. We used sensitive bioassays to measure net TNF-alpha, IL-1 beta, and IL-6 activity. Although individual cytokines increased before and after onset of ARDS, greater increases occurred in cognate receptors and/or antagonists, so that molar ratios of agonists/antagonists declined dramatically at the onset of ARDS. The molar ratios remained low for 7 d or longer, limiting the activity of soluble IL-1 beta and TNF-alpha in the lungs at the onset of ARDS. This significant antiinflammatory response early in ARDS may provide a key mechanism for limiting the net inflammatory response in the lungs.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11734443     DOI: 10.1164/ajrccm.164.10.2104013

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  190 in total

1.  Sources of alveolar soluble TNF receptors during acute lung injury of different etiologies.

Authors:  Anthony D Dorr; Michael R Wilson; Kenji Wakabayashi; Alicia C Waite; Brijesh V Patel; Nico van Rooijen; Kieran P O'Dea; Masao Takata
Journal:  J Appl Physiol (1985)       Date:  2011-04-21

2.  Death receptors mediate the adverse effects of febrile-range hyperthermia on the outcome of lipopolysaccharide-induced lung injury.

Authors:  Anne B Lipke; Gustavo Matute-Bello; Raquel Herrero; Venus A Wong; Stephen M Mongovin; Thomas R Martin
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-04-22       Impact factor: 5.464

Review 3.  Into the eye of the cytokine storm.

Authors:  Jennifer R Tisoncik; Marcus J Korth; Cameron P Simmons; Jeremy Farrar; Thomas R Martin; Michael G Katze
Journal:  Microbiol Mol Biol Rev       Date:  2012-03       Impact factor: 11.056

4.  Exploration of the normal human bronchoalveolar lavage fluid proteome.

Authors:  Jinzhi Chen; Soyoung Ryu; Sina A Gharib; David R Goodlett; Lynn M Schnapp
Journal:  Proteomics Clin Appl       Date:  2008-04       Impact factor: 3.494

5.  A clinically applicable porcine model of septic and ischemia/reperfusion-induced shock and multiple organ injury.

Authors:  Brian D Kubiak; Scott P Albert; Louis A Gatto; Christopher J Vieau; Shreyas K Roy; Kathleen P Snyder; Kristopher G Maier; Gary F Nieman
Journal:  J Surg Res       Date:  2010-11-12       Impact factor: 2.192

6.  Immunological priming requires regulatory T cells and IL-10-producing macrophages to accelerate resolution from severe lung inflammation.

Authors:  Neil R Aggarwal; Kenji Tsushima; Yoshiki Eto; Ashutosh Tripathi; Pooja Mandke; Jason R Mock; Brian T Garibaldi; Benjamin D Singer; Venkataramana K Sidhaye; Maureen R Horton; Landon S King; Franco R D'Alessio
Journal:  J Immunol       Date:  2014-03-31       Impact factor: 5.422

7.  Plasma adiponectin and mortality in critically ill subjects with acute respiratory failure.

Authors:  Allan J Walkey; Todd W Rice; Jason Konter; Noriyuki Ouchi; Rei Shibata; Kenneth Walsh; Bennett P deBoisblanc; Ross Summer
Journal:  Crit Care Med       Date:  2010-12       Impact factor: 7.598

8.  IL-1β suppression of VE-cadherin transcription underlies sepsis-induced inflammatory lung injury.

Authors:  Shiqin Xiong; Zhigang Hong; Long Shuang Huang; Yoshikazu Tsukasaki; Saroj Nepal; Anke Di; Ming Zhong; Wei Wu; Zhiming Ye; Xiaopei Gao; Gadiparthi N Rao; Dolly Mehta; Jalees Rehman; Asrar B Malik
Journal:  J Clin Invest       Date:  2020-07-01       Impact factor: 14.808

9.  Interleukin-10 polymorphism in position -1082 and acute respiratory distress syndrome.

Authors:  M N Gong; B T Thompson; P L Williams; W Zhou; M Z Wang; L Pothier; D C Christiani
Journal:  Eur Respir J       Date:  2006-04       Impact factor: 16.671

10.  Critical role of PBEF expression in pulmonary cell inflammation and permeability.

Authors:  Peng Liu; Hailong Li; Javier Cepeda; Li Qin Zhang; Xiuyun Cui; Joe G N Garcia; Shui Qing Ye
Journal:  Cell Biol Int       Date:  2008-11-01       Impact factor: 3.612

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.